Comment on

• Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells.

  Nassif A, Bensussan A, Boumsell L, Deniaud A, Moslehi H, Wolkenstein P, Bagot M, Roujeau JC. Nassif A, et al. J Allergy Clin Immunol. 2004 Nov;114(5):1209-15. doi: 10.1016/j.jaci.2004.07.047. J Allergy Clin Immunol. 2004. PMID: 15536433
• HLA-B*1502-bound peptides: implications for the pathogenesis of carbamazepine-induced Stevens-Johnson syndrome.

  Yang CW, Hung SI, Juo CG, Lin YP, Fang WH, Lu IH, Chen ST, Chen YT. Yang CW, et al. J Allergy Clin Immunol. 2007 Oct;120(4):870-7. doi: 10.1016/j.jaci.2007.06.017. Epub 2007 Aug 13. J Allergy Clin Immunol. 2007. PMID: 17697703
• Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens-Johnson syndrome.

  Ko TM, Chung WH, Wei CY, Shih HY, Chen JK, Lin CH, Chen YT, Hung SI. Ko TM, et al. J Allergy Clin Immunol. 2011 Dec;128(6):1266-1276.e11. doi: 10.1016/j.jaci.2011.08.013. Epub 2011 Sep 14. J Allergy Clin Immunol. 2011. PMID: 21924464